Tighe Reardon's Net Worth

$103 Million

Estimate Recalculated Jul 22, 2024 07:06PM EST

Who is Tighe Reardon?

Tighe Reardon has an estimated net worth of $103 Million. This is based on reported shares across multiple companies, which include Janux Therapeutics, Inc., and Synthorx, Inc..

SEC CIK

Tighe Reardon's CIK is 0001760431

Past Insider Trading and Trends

2018 was Tighe Reardon's most active year for acquiring shares with 3 total transactions. Tighe Reardon's most active month to acquire stocks was the month of May. 2020 was Tighe Reardon's most active year for disposing of shares, totalling 4 transactions. Tighe Reardon's most active month to dispose stocks was the month of December. 2021 saw Tighe Reardon paying a total of $10,699,987.00 for 4,479,492 shares, this is the most they've acquired in one year. In 2020 Tighe Reardon cashed out on 1,774,497 shares for a total of $120,248,921.28, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Janux Therapeutics, Inc. (JANX) Snapshot price: $8.79

Acting Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-17.15%
-822.72K
$54.75
-$45,043,974.75
3.97M
Jun 3
Form 4
—
0
—
—
0
Jan 2
Form 4
∞
849.85K
$5.87
$4,988,642.98
849.85K
Nov 13
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jan 3
Form 4
∞
4.48M
$17.00
—
4.48M
Jun 15
Form 3
—
0
—
—
0
No matching records found

Synthorx, Inc. No price found

Acting Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.73M
$68.00
-$117,352,632.00
0
Jan 23
Form 4
∞
1.68M
$11.00
—
1.68M
Dec 11
Form 4
—
0
—
—
0
Dec 6
Form 3
—
0
—
—
0
No matching records found